TAHP Medical + Pharmacy Directors Forum

These invitation-only events offer our health plan Medical and Pharmacy Directors the unique opportunity to interface with their peers and hear from state and national experts as they discuss common challenges and best practices.  If you are interested in sponsoring and presenting at this forum email pdoner@tahp.org for more information. This meeting is only open to our health plan MDs & PharmDs.

Hampton Inn 200 San Jacinto Blvd, Austin, TX

Oct 24, 2023

9:00 am - 3:30 pm



9:00 - 9:45am

The Healthy Equity and Cost Benefits of Immunoglobulin Infusions at Home

Immunoglobulins, derived from donated human plasma, are used in the treatment of hundreds of disease states, including immunodeficiencies and autoimmune disorders. This presentation will cover the use of immunoglobulin (Ig) therapy in these various conditions, as well as the importance of the clinician’s role in the individualization of care and Ig treatment planning. Topics will include strategies for cost containment and the health equity benefits of home infusion as a site of care.


  • James Sheets, CEO, CSI Pharmacy
  • Ed O’Bryan, CMO, CSI Pharmacy

9:50 - 10:35am

How Virtual Health Engagement drives successful P4Q and NMDOH

Pay For Quality and Non-Medical Drivers are Health are among the top 2 priorities for Texas Medicaid in 2024 and beyond. During this talk, you will learn how the right virtual health engagement strategy improves health outcomes, leading to over performing on P4Q and NMDOH.


  • Shameet Luhar, CEO, Vheda Health

10:40 - 11:25am

Patient journey to an approved Alzheimer’s disease treatment for patients with Early Alzheimer’s Disease

Alzheimer’s disease (AD) is a growing public health crisis and represents a crucial unmet need in healthcare. New AD diagnostic tools and therapies are evolving the management of AD, changing the patient journey towards earlier identification and treatment initiation.

During this program, we will overview the patient journey to treatment with a therapy and discuss signs and diagnosis of early AD, the clinical trial data in informing selection for treatment for appropriate patients, key considerations for initiating the treatment, monitoring for safety, and economic impact of early intervention.


  • Angelo DeLuca, PharmD, Director, HEOR at Eisai Inc

11:30 - 12:15pm


12:15 - 1:05pm

MDI Health Technologies - Presentation


More Agenda Item Coming Soon!


James Sheets, PharmD

CEO, CSI Pharmacy

Edward O’Bryan, MD, MBA, CPE

CMO, CSI Pharmacy

Shameet Luhar

CEO, Vheda Health

Angelo DeLuca, PharmD

Director, HEOR at Eisai Inc

Become a Sponsor

If you are interested in sponsoring one of our upcoming forums or other events please complete the request to sponsor form. Please make sure to include the event of interest.